. Author manuscript; available in PMC: 2018 Jan 18.

Published in final edited form as: Scand J Gastroenterol. 2017 Aug 4;52(11):1263–1269. doi: 10.1080/00365521.2017.1359664

Table 1.

Demographics of alcoholic hepatitis (AH) patients and heavy drinking matched controls without hepatitis.

Variables	Controls (n = 93)	AH cases (n = 90)	p-value
Age (years)	44.6 ± 12.2	46.8 ± 11.0	0.21
Men, n (%)	56 (60%)	56 (62%)	0.78
BMI (kg/m²)	29.1 ± 7.3	29.6 ± 8.3	0.71
WBC (10³ cells/mm³)	7.2 ± 2.8	11.1 ± 8.1	< 0.0001
Hemoglobin (g/dl)	13.3 ± 1.7	10.1 ± 1.9	< 0.0001
Platelet count (10³ cells/mm³)	245.2 ± 71.9	139.3 ± 82.0	< 0.0001
Total bilirubin (mg/dL)	0.5 ± 0.3	14.2 ± 12.5	< 0.0001
INR	1.0 ± 0.1	1.8 ± 0.5	< 0.0001
AST (U/L)	27.0 ± 8.4	134.2 ± 78.2	< 0.0001
ALT (U/L)	26.0 ± 9.9	64.4 ± 78.2	< 0.0001
Albumin (g/dL)	3.9 ± 0.6	2.9 ± 0.7	< 0.0001
Creatinine (mg/dL)	0.8 ± 0.2	1.1 ± 1.0	0.0143
MELD score	6.8 ± 1.5	22.4 ± 7.6	< 0.0001
Total drinks in the past 30 days (TLFB)	383.3 ± 294.2	232.3 ± 263.0	0.0004
AUDIT score	29.5 ± 6.7	22.8 ± 9.2	0.0001

BMI, body mass index; WBC, white blood cell; INR, international normalized ratio; AST, aspartate transaminase; ALT, alanine transaminase; MELD, Model For End-Stage Liver Disease; TLFB, Time Line Follow-Back; AUDIT, Alcohol Use Disorders Identification Test.